 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Reprints |
| Permissions |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REWIEWS MOLECULAR IMAGING IN PHARMACOLOGY
The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007 June;51(2):99-110
Copyright © 2007 EDIZIONI MINERVA MEDICA
language: English
Nuclear medicine applications in molecular imaging: 2007 update
Blankenberg F. G. 1, Strauss H. W. 2
1 Division of Pediatric Radiology F.G.B.-Department of Radiology Lucile Salter Packard Children’s Hospital, Stanford, CA, USA 2 Section of Nuclear Medicine H.W.S.-Department of Radiology Memorial Sloan Kettering Cancer Center, NY, USA
This review examines several classes of radiolabeled agents, including analogs localizing in somatostatin, benzodiazepine and dopamine receptors; analogs of progesterone and estrogen; and agents localizing in lesions with hypoxia. It concludes the status of agents advocated for detecting angiogenesis and inflammation. The current clinical status of these agents, and their potential roles in diagnosis and treatment are discussed.